Sharechat Logo

Blis gains access to Korean market


Tuesday 26th November 2002

Text too small?
Listed biotechnology company Blis has gained access to the Korean market.

Blis's K12 Throat Guard product has initially been focused on the the New Zealand and European markets but a partnership with Australian company Astra Grace will give it access to Korea.

Blis Technologies chief executive Kelvin Moffat said it was the company's first foray into Asia.

"With a population of 50 million, Korea is obviously an exciting market. We also see a priority in establishing a presence in Japan and Taiwan. Then there is the massive Chinese market as well," he said.

Mr Moffat said the Throat Guard, a bacteria-laden lozenge aimed at preventing sore throats, was the first of several products to be rolled out in the next few years.

A second product aimed at oral and intestinal health would be on the market early next year, and a tooth decay preventative was also in the pipeline.

  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

BLIS Technologies announces a net deficit of $1,856k for the March 2013 financial year
Blis share price spike
Blis to clean up share register, buying small parcels
Blis K12 probiotic to get ruff ruff test in dogs
BLIS Technology forecasts wider 2013 loss, seeks to raise capital